Circulating Tumor DNA Testing Opens New Perspectives in Melanoma Management

Circulating Tumor DNA Testing Opens New Perspectives in Melanoma Management

Malignant melanoma accounts for about 1% of all skin cancers, but it causes most of the skin cancer-related deaths. Circulating tumor DNA (ctDNA) testing is emerging as a relevant tool for the diagnosis and monitoring of cancer. The availability of highly sensitive techniques, including next generat...

Full description

Bibliographic Details
Main Authors: Alessandra Sacco, Laura Forgione, Marianeve Carotenuto, Antonella De Luca, Paolo A. Ascierto, Gerardo Botti, Nicola Normanno
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cancers
Subjects:
ctDNA
melanoma
liquid biopsy
prognosis
prediction
patient stratification
Online Access:https://www.mdpi.com/2072-6694/12/10/2914

Internet

https://www.mdpi.com/2072-6694/12/10/2914

Similar Items